E-LIB Suche - Ergebnisse für: Deakin, Claire

1

The Impact of Immunocompromise on Outcomes of COVID-19 in C..:

Greenan-Barrett, James ; Deakin, Claire ; Aston, Samuel.
https://discovery.ucl.ac.uk/id/eprint/10165301/1/COVID%20in%20immunosuppressed.pdf. , 2023

Link: https://discovery.ucl.ac..

2

The impact of immunocompromise on outcomes of COVID-19 in c..:

Greenan-Barrett, James ; Aston, Samuel ; Deakin, Claire.
https://discovery.ucl.ac.uk/id/eprint/10174673/7/Ciurtin_fimmu-14-1159269.pdf. , 2023

Link: https://discovery.ucl.ac..

3

Rituximab in myositis: where are we now? A survey of curren..:

Oliveira, Tatiana ; Yıldırım, Reşit ; Deakin, Claire.
https://discovery.ucl.ac.uk/id/eprint/10163493/2/Isenberg_Letter%20to%20Editor%20Rheumatology%2029.11-%20last%20version.pdf. , 2023

Link: https://discovery.ucl.ac..

4

Focused HLA analysis in Caucasians with myositis identifies..:

Rothwell, Simon ; Chinoy, Hector ; Lamb, Janine...
info:eu-repo/semantics/altIdentifier/doi/10.1136/annrheumdis-2019-215046. , 2019

Link: https://hal.science/hal-..

5

Focused HLA analysis in Caucasians with myositis identifies..:

Rothwell, Simon ; Chinoy, Hector ; Lamb, Janine...
info:eu-repo/semantics/altIdentifier/doi/10.1136/annrheumdis-2019-215046. , 2019

Link: https://hal.science/hal-..

6

Comparison of the Utility and Validity of Three Scoring Too..:

Campanilho‐Marques, Raquel ; Almeida, Beverley ; Deakin, Claire...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053292/. , 2016

Link: http://www.ncbi.nlm.nih...

7

Comparative Effectiveness of Adalimumab vs Tofacitinib in P..:

Deakin, Claire T ; De Stavola, Bianca L ; Littlejohn, Geoffrey...
https://www.repository.cam.ac.uk/handle/1810/353480. , 2023

Link: https://www.repository.c..

8

A novel electronic patient-reported outcome delivery system..:

Tymms, Kathleen ; O'Sullivan, Catherine ; Smith, Tegan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869675/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Comparative Effectiveness of First‐Line Baricitinib in Pati..:

Ciciriello, Sabina ; Littlejohn, Geoffrey ; Treuer, Tamas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349226/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Association with HLA-DRβ1 position 37 distinguishes juvenil..:

Deakin, Claire T ; Bowes, John ; Rider, Lisa G...
https://discovery.ucl.ac.uk/id/eprint/10143154/1/ddac019.pdf. , 2022

Link: https://discovery.ucl.ac..

11

Association with HLA-DRβ1 position 37 distinguishes juvenil..:

Deakin, Claire T ; Bowes, John ; Rider, Lisa G...
Deakin, Claire T. Bowes, John Rider, Lisa G. Miller, Frederick W. Pachman, Lauren M. Sanner, Helga Rouster-Stevens, Kelly Mamyrova, Gulnara Curiel, Rodolfo Feldman, Brian M. Huber, Adam M. Reed, Ann M. Schmeling, Heinrike Cook, Charlotte G. Marshall, Lucy R. Ll Wilkinson, Meredyth G. Eyre, Stephen Raychaudhuri, Soumya Wedderburn, Lucy R. . Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis. Human Molecular Genetics. 2022, 31(14), 2471-2481. , 2022

Link: http://hdl.handle.net/10..

12

Adalimumab or Etanercept as first line biologic therapy in ..:

Shipa, Muhammad RA ; Heyer, Nicola ; Mansoor, Rashid...
https://discovery.ucl.ac.uk/id/eprint/10149975/2/Shipa_1-s2.0-S0049017222000890-main.pdf. , 2022

Link: https://discovery.ucl.ac..

13

Role of CD14+ monocyte-derived oxidised mitochondrial DNA i..:

Wilkinson, Meredyth G Ll ; Moulding, Dale ; McDonnell, Thomas CR...
https://discovery.ucl.ac.uk/id/eprint/10162346/1/ard-2022-223469.full.pdf. , 2022

Link: https://discovery.ucl.ac..

14

Retrospective analysis of infliximab and adalimumab treatme..:

Campanilho-Marques, Raquel ; Deakin, Claire T ; Simou, Stefania...
https://arthritis-research.biomedcentral.com/. , 2021

Link: http://hdl.handle.net/10..

15

JAK inhibitors: a potential treatment for JDM in the contex..:

Ll Wilkinson, Meredyth G ; Deakin, Claire T ; Papadopoulou, Charalampia..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466894/. , 2021

Link: http://www.ncbi.nlm.nih...